Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis
Teng Y, Fan X, Yu R, Yang X
BMC Endocr Disord. 2024;24(1):278.
Leggi
Teng Y, Fan X, Yu R, Yang X
BMC Endocr Disord. 2024;24(1):278.
Leggi
Zhu X, Fowler MJ, Wells QS, et al.
BMC Endocr Disord. 2024;24(1):269.
Leggi
Karges B, Rosenbauer J, Stahl-Pehe A, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00284-5.
Leggi
Wang Y, Lu J, Yu J, et al.
Diabetes Obes Metab. Pub. online 18 Dec 2024.
Leggi
Gargouri I, Charfi H, Belabed W, et al.
Diabetes Obes Metab. Pub. online 17 Dec 2024.
Leggi
Stefan N, Yki-Järvinen H, Neuschwander-Tetri BA
Lancet Diabetes Endocrinol. Pub. online 13 Dec 2024.
Leggi
Immanuel J, Cheung NW, Mohajeri M, et al.
Diabetes Care. 2024:dc241199
Leggi
Barnard-Kelly K, Marrero D, de Wit M, et al. Diabet Med. 2024:e15484 Abstract
Leggi
Butt JH, Henderson AD, Jhund PS, et al.
J Am Coll Cardiol. 2024:S0735-1097(24)10423-8.
Leggi
Franceschi R, Pertile R, Marigliano M, et al.
Diabetes Res Clin Pract. 2024:111962.
Leggi